Bibliography
- YANAGISAWA M, KURIHARA H, KIMURA S et al.: A novelpotent vasoconstrictor peptide produced by vascular endothelial cells. Nature (1988) 332:411–415.
- AMES RS, SARAU HM, CHAMBERS JK et al.: Humanurotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14. Nature (1999) 401:282–286.
- ARAI H, HORI S, ARAMORI I, OHKUBU H, NAKANISHI S: Cloning and expression of a cDNA encoding an endothelin receptor. Nature (1990) 348:730–732.
- TAKAYANAGI R, KITAZUMI K, TAKASAKI C et al.: Presence of non-selective type of endothelin receptor on vascular endothelium and its linkage to vasodila-tion. FEBS Lett. (1991) 282:103–106.
- SUMNER MJ, CANNON TR, MUNDIN JW, WHITE DG, WATTS IS: Endothelin ETA and ETB receptors mediate vascular smooth muscle contraction. Br. J. Pharmacol (1992) 107:858–860.
- KURIHARA Y, KURIHARA H, SUZUKI H et al: Elevated blood pressure and craniofacial abnormalities in mice deficient in endothelin-1. Nature (1994) 368:703–710.
- BAYNASH AG, HOSODA K, GIAID A et al.: Interaction ofendothelin-3 with endothelin-B receptor is essential for development of epidermal melanocytes and enteric neurons. Cell (1994) 79:1277–85.
- SUTSCH G, KIOWSKI W, YAN XW et al.: Short-term oralendothelin-receptor antagonist therapy in conven-tionally treated patients with symptomatic severe chronic heart failure. Circulation (1998) 98:2262–2268.
- MATSUMURA Y, TAIRA S, KITANO R, HASHIMOTO N, KURO T: Selective antagonism of endothelin ET(A) or ET(B) receptor in renal hemodynamics and function of deoxycorticosterone acetate-salt-induced hyperten-sive rats. Biol. Pharm. Bull. (1999) 22:858–862.
- GRAY GA, BATTISTINI B, WEBB DJ: Endothelins are potent vasoconstrictors, and much more besides. Trends Pharmacol. ScL (2000) 21:38–40.